Vericiguat and heart function in heart failure patients
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether vericiguat can improve heart function in people with stable heart failure and a reduced pumping ability. It may help if you have not needed hospital or IV treatments for worsening heart failure in the last 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and agree to join the study
- You have chronic heart failure with a reduced pumping ability (LVEF 40% or less, confirmed by an ultrasound of the heart)
- Your heart failure has been stable for at least 6 months (no hospital stays or extra water pills needed)
- You have been on steady heart failure medications for at least 3 months
- You do not have very low blood pressure (below 100) or symptoms from low blood pressure
- You are not currently using or planning to use nitrates, certain other heart medicines (like sildenafil), or have had recent heart procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called vericiguat against standard treatments to see if it helps people with worsening heart failure. It may be an option if you have heart failure with a weak heart pump and recently needed more medical help.
This study checks how safe the medicine vericiguat is for Japanese people with chronic heart failure when used in everyday care. It compares patients who receive vericiguat with patients who continue standard treatments without vericiguat.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This trial tests a medication called Vericiguat for people with heart failure and a weak heart pump after a past heart attack. It aims to see if the drug can help improve your condition.
This trial tests a drug called vericiguat to see if it helps people with heart failure affecting the right side of the heart and a leaky tricuspid valve. You may qualify if you have a weak right ventricle, a low pump strength in the left ventricle, and symptoms that have recently gotten worse.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.